GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (OTCPK:EDTXF) » Definitions » Change In Payables And Accrued Expense

Spectral Medical (Spectral Medical) Change In Payables And Accrued Expense : $-0.18 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Spectral Medical Change In Payables And Accrued Expense?

Spectral Medical's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $0.74 Mil. It means Spectral Medical's Accounts Payable & Accrued Expense increased by $0.74 Mil from Sep. 2023 to Dec. 2023 .

Spectral Medical's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $-0.20 Mil. It means Spectral Medical's Accounts Payable & Accrued Expense declined by $0.20 Mil from Dec. 2022 to Dec. 2023 .

Spectral Medical Change In Payables And Accrued Expense Historical Data

The historical data trend for Spectral Medical's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical Change In Payables And Accrued Expense Chart

Spectral Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.89 -0.48 1.15 -0.20

Spectral Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 -0.84 0.35 -0.42 0.74

Spectral Medical Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spectral Medical Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Spectral Medical's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Spectral Medical (Spectral Medical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (OTCPK:EDTXF) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
XCNQ:SONA XCNQ:BUX TSXV:AVCR TSXV:TELO TSXV:ARC XCNQ:IZO TSXV:JUMP TSX:SZLS TSXV:MBI.H XCNQ:VTAL TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT
Traded in Other Exchanges
SD4:Germany EDT:Canada
Address
135 - 2 The West Mall, Finance, Toronto, ON, CAN, M9C 1C2
Website
https://www.spectraldx.com
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.